Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)

Clinical and Experimental Immunology

Volumn 104, Issue 3, 1996, Pages 446-453

  Spronk, P E ^a   Horst, G ^a   Van Der Gun, B T F ^a   Limburg, P C ^b   Kallenberg, C G M ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti dsDNA; Lymphocyte activation; Prospective study; Systemic lupus erythematosus

Indexed keywords

CD20 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; DNA ANTIBODY; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0030023679     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.44754.x     Document Type: Article

References (44)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune disease and probes for cell biology. Adv Immunol 1989; 44:93-151.
2. Fauci AS, Moutsopoulos HM. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum 1981; 24:577-84.
3. Pelton BK, Speckmaier M et al. Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with sustemic lupus erythematosus. Clin Exp Immunol 1991; 83:274-9.
4. ter Borg EJ, Horst G, Limburg PC, Kallenberg CGM. Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. Clin Exp Immunol 1990; 82:21-26.
5. Danieli MG, Paoletti P, Recchioni A, Gabrielli A, Danieli G. Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. Scand J Rheumatol 1993; 22:215-9.
6. + T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. Scand J Immunol 1990; 31: 139-45.
7. Spronk PE, Gun BTF van der, Limburg PC, Kallenberg CGM. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation. Clin Exp Immunol 1993; 93:39-44.
8. Murakami M, Sumagai M, Sugita M, Iwai K, Imura H. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA-DR restricted T cell clone. Clin Exp Immunol 1992; 90:245-50.
9. ter Borg EJ, Horst G, Hummel E, Limburg PC, Kallenberg CGM. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus, a long term, prospective study. Arthritis Rheum 1990; 33:634-43.
10. Spronk PE, Borg EJ ter, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity? Clin Exp Immunol 1992; 90:106-10.
11. Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest 1995; 75:1270-7.
12. Davidson A, Manheimer-Lory A, Aranow C, Peterson R, Hannigan N, Diamond B. Molecular characterization of a somatically mutated anti-DNA antibody bearing two systemic lupus crythematosus-related idiotypes. J Clin Invest 1990; 85:1401-9.
13. Es JH van, Gmelig Meyling F, Akker WR van de, Aanstoot H, Derksen RHWM, Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med 1991; 173:461-70.
14. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-5.
15. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35:630-40.
16. Levi FA, Canon C, Touiyou Y et al. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosteron, total and free cortisol in five healthy men. Clin Exp Immunol 1988; 71:329-35.
17. + and CD5 B cells of patients with systemic lupus erythematosus. J Clin Invest 1990; 85:238-47.
18. Zola H, MacArdle PJ, Flego L, Webster J. The expression of subpopulation markers on B-cells: re-evaluation using high-sensitivity fluorescence flow-cytometry. Disease Markers 1991; 9:103-18.
19. Funaro A, De Monte LB, Dianzani U, Forni M, Malavasi F. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages. Eur J Immunol 1993; 23:2407-11.
20. Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B-cell activation. J Exp Med 1987; 165: 1755-60.
21. ter Borg EJ, Horst G, Hummel E, Limburg PC, Kallenberg CGM. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation. Clin Immunol Immunopathol 1991; 59:117-28.
22. + cells to support autoantibody synthesis. Arthritis Rheum 1990; 33:1216-25.
23. Schwab J, Lukowsky A, Volk H-D, Peter HH, Melchers I. Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1994; 96:450-1.
24. Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM. NIH conference. Systemic lupus erythematosus. Ann Intern Med 1991; 115:548-59.
25. Isenberg DA, Ehrenstein MR, Longhurst C, Kalsi JK. Viewpoint: the origin, sequence, structure, and consequences of developing anti-DNA antibodies: a human perspective. Arthritis Rheum 1994; 37:169-80.
26. Kipps TJ. The CD5 B cell. Adv Immunol 1989; 47:117-85.
27. + B cells. J Immunol 1990; 144:4520-5.
28. + B cells. Clin Immunol Immunopathol 1990; 56:135-50.
29. Casali P, Burastero SE, Balow JE, Notkins AL. High-affinity antibodies to ssDNA are produced by CD5- B cells in systemic lupus erythematosus patients. J Immunol 1989; 143:3476-83.
30. Dauphinee M, Tovar Z, Talal N. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum 1988; 31: 642-7.
31. + B lymphocytes and the activity of systemic autoimmunity. Clin Immunol Immunopathol 1990; 56:219-25.
32. + B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 1990; 17: 833-5.
33. Fredriksen K, Skogsholm A, Fl'gstad T, Traavik T, Rekvig OP. Antibodies to dsDNA are produced during primary BK virus infection in man, indicating that anti-dsDNA antibodies may be related to virus replication in vivo. Scand J Immunol 1993; 38:401-6.
34. Price P, Olver SD, Gibbons AE, Shellam GR. B-cell activation following murine cytomegalovirus infection: implications for autoimmunity. Immunology 1993; 78:14-21.
35. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G. Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37:57-66.
36. Garzelli C, Incaprera M, Bazzichi A, Manunta M, Rognini F, Falcone G. Epstein-Barr virus-transformed human B lymphocytes produce natural antibodies to histones. Immunol Letters 1994; 39:277-82.
37. Shi Y, Szalay L, Paskar L, Boyer M, Singh B, Green DR. Activation-induced cell death in T cell hybridomas is due to apoptosis: morphologic aspects and DNA fragmentation. J Immunol 1990; 144:3226.
38. Kabelitz D, Pohl T, Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 1993; 14:338-9.
39. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685-92.
40. Krishnan MR, Marion TN. Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies. J Immunol 1993; 150:4948-57.
41. Rumore P, Steinmann C. Endogenous circulating DNA in systemic lupus erythematosus: occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86:69-74.
42. Franek F, Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell culture. Evidence for programmed cell death FEBS Letters 1991; 284:285-7.
43. Emlen W. Binding of apoptotic cells by human macrophages. Arthritis Rheum 1992; 35:S167.
44. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T-cells of lupus. J Exp Med 1993; 177:1367-81.